Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Wj Huizinga

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|July 13, 2019
On using machine learning algorithms to define clinically meaningful patient subgroupsRachel Knevel, Tom Wj Huizinga
RMD Open|December 4, 2024
Is AI-assisted active learning software able to reliably speed-up systematic literature reviews in rheumatology? A real-time comparison of AI-assisted and manual abstract selectionJoy Ardjuna van der Pol, Tom Wj Huizinga, Sytske Anne Bergstra
The Lancet. Rheumatology|May 11, 2026
When one joint matters: the monoarticular blind spot in inflammatory arthritisFrancesco Ursini, Jacopo Ciaffi, Salvatore D'Angelo, et al.
Annals of the Rheumatic Diseases|March 3, 2022
No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 yearsMarloes Verstappen, Tom Wj Huizinga, Annette Hm van der Helm-van Mil
Annals of the Rheumatic Diseases|June 24, 2019
Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RAXanthe Me Matthijssen, Tom Wj Huizinga, Ellis Niemantsverdriet, et al.
Annals of the Rheumatic Diseases|January 28, 2022
Management of contemporary early undifferentiated arthritis: data on EULAR's recommendation on the risk of persistent diseaseNikolet K den Hollander, Marloes Verstappen, Tom Wj Huizinga, et al.
BMC Proceedings|December 19, 2009
Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modelingJérémie Jp Lebrec, Tom Wj Huizinga, René Em Toes, et al.
Journal of Multidisciplinary Healthcare|December 3, 2011
Role of rheumatology clinical nurse specialists in optimizing management of hand osteoarthritis during daily practice in secondary care: an observational studyWing-Yee Kwok, Margreet Kloppenburg, Liesbeth Jj Beaart-van de Voorde, et al.
Annals of the Rheumatic Diseases|January 17, 2014
Predicting the severity of joint damage in rheumatoid arthritis; the contribution of genetic factorsHanna W van Steenbergen, Roula Tsonaka, Tom Wj Huizinga, et al.
Pharmacogenomics|June 23, 2017
Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritisFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|July 13, 2019
On using machine learning algorithms to define clinically meaningful patient subgroupsRachel Knevel, Tom Wj Huizinga
RMD Open|December 4, 2024
Is AI-assisted active learning software able to reliably speed-up systematic literature reviews in rheumatology? A real-time comparison of AI-assisted and manual abstract selectionJoy Ardjuna van der Pol, Tom Wj Huizinga, Sytske Anne Bergstra
The Lancet. Rheumatology|May 11, 2026
When one joint matters: the monoarticular blind spot in inflammatory arthritisFrancesco Ursini, Jacopo Ciaffi, Salvatore D'Angelo, et al.
Annals of the Rheumatic Diseases|March 3, 2022
No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 yearsMarloes Verstappen, Tom Wj Huizinga, Annette Hm van der Helm-van Mil
Annals of the Rheumatic Diseases|June 24, 2019
Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RAXanthe Me Matthijssen, Tom Wj Huizinga, Ellis Niemantsverdriet, et al.
Annals of the Rheumatic Diseases|January 28, 2022
Management of contemporary early undifferentiated arthritis: data on EULAR's recommendation on the risk of persistent diseaseNikolet K den Hollander, Marloes Verstappen, Tom Wj Huizinga, et al.
BMC Proceedings|December 19, 2009
Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modelingJérémie Jp Lebrec, Tom Wj Huizinga, René Em Toes, et al.
Journal of Multidisciplinary Healthcare|December 3, 2011
Role of rheumatology clinical nurse specialists in optimizing management of hand osteoarthritis during daily practice in secondary care: an observational studyWing-Yee Kwok, Margreet Kloppenburg, Liesbeth Jj Beaart-van de Voorde, et al.
Annals of the Rheumatic Diseases|January 17, 2014
Predicting the severity of joint damage in rheumatoid arthritis; the contribution of genetic factorsHanna W van Steenbergen, Roula Tsonaka, Tom Wj Huizinga, et al.
Pharmacogenomics|June 23, 2017
Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritisFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.
Pageof 5